Historical record - last NADAC effective date: 6/3/2024
Product Information
DILAUDID 4 MG TABLET is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $3.9559 per EA under NDC 42858023450. Its NADAC has been published 61 times since Apr 17, 2024.
FDA first approved this application on Dec 7, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858023450
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/3/2024
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019892FDA Approved
12/7/1992
TE Code
AB
On Market Since
5/15/2017
Pharmacological Classes
Price Statistics
The NADAC for DILAUDID 4 MG TABLET has been published 61 times since Apr 17, 2024, and over the history we have for it it has risen 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9559 per EA |
|---|---|
| All-time high | $3.9559 (Jun 11, 2025) |
| All-time low | $3.6200 (Apr 17, 2024) |
| Median price | $3.9559 |
| Average price | $3.9177 |
| Largest weekly change | +9.0% (Jun 5, 2024) |
| Weeks tracked | 61 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+9.3%
Last surveyed Jun 11, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DILAUDID 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DILAUDID 4 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $3.9559 per EA (NDC 42858023450), effective Jun 11, 2025.
How has the price of DILAUDID 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for DILAUDID 4 MG TABLET has risen 9.3%. It has been tracked across 61 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DILAUDID 4 MG TABLET?
Since Apr 17, 2024, the NADAC for DILAUDID 4 MG TABLET has ranged from a low of $3.6200 (Apr 17, 2024) to a high of $3.9559 (Jun 11, 2025), with a median of $3.9559 per EA.
Are there cheaper alternatives to DILAUDID 4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROMORPHONE 4 MG TABLET, is $0.2168 per EA — about 95% below DILAUDID 4 MG TABLET.
Who manufactures DILAUDID 4 MG TABLET?
DILAUDID 4 MG TABLET (NDC 42858023450) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.